×
<- Back

Understanding the Agents Used to Treat Acute Lymphoblastic Leukemia

  • : Online

The Understanding the Agents Used to Treat Acute Lymphoblastic Leukemia learning program is designed to introduce the agents used to treat acute lymphoblastic leukemia (ALL) and the cellular processes these agents target. The variety of therapeutic agents used reflects the diversity of cellular processes that can be exploited as a therapeutic target for ALL. This program will first introduce the different phases of ALL treatment followed by the different potential therapeutic agents along with the cellular processes they target including gene activity cell division protein synthesis DNA replication and intracellular signal transduction. The program will also cover the mechanisms of action and of resistance for each therapeutic agent as well as additional therapies for ALL including supportive and palliative care and stem cell transplantatio

 

Upon completion of this learning program you will be able to::

  • List the agents that are used in the treatment of ALL.
  • Identify the therapeutic targets of the agents used in the treatment of ALL.
  • Describe the proposed mechanisms of action of the agents used in the treatment of ALL.
  • Describe the mechanisms responsible for the development of resistance to the agents used in the treatment of ALL.
  • Recall additional therapies used in the context of ALL, including supportive therapies, stem cell transplantation, and palliative care. 

 

  • WELCOME
  • DISCLAIMER
  • NAVIGATION INSTRUCTIONS
  • INTRODUCTION
  • LEARNING OBJECTIVES
  • INTRODUCTION TO ALL TREATMENT
  • REGULATION OF GENE ACTIVITY
  • HOW IS GENE ACTIVITY REGULATED?
  • THERAPEUTIC TARGET
  • THERAPY – GLUCOCORTICOIDS
  • PROGRESS CHECK
  • SECTION SUMMARY
  • INHIBITION OF CELL DIVISION
  • WHAT IS CELL DIVISION?
  • THERAPEUTIC TARGET
  • THERAPY – VINCA ALKALOIDS
  • POP QUIZ
  • SECTION SUMMARY
  • INDUCTION OF DNA DAMAGE
  • WHAT IS DNA DAMAGE?
  • THERAPEUTIC TARGET
  • THERAPY – ANTHRACYCLINES
  • THERAPY – EPIPODOPHYLLOTOXINS
  • THERAPY – ALKYLATING AGENTS
  • PROGRESS CHECK
  • SECTION SUMMARY
  • INHIBITION OF PROTEIN SYNTHESIS
  • WHAT IS PROTEIN SYNTHESIS?
  • THERAPEUTIC TARGET
  • THERAPY – ASPARAGINASE
  • POP QUIZ
  • SECTION SUMMARY
  • INHIBITION OF DNA REPLICATION
  • WHAT IS DNA REPLICATION?
  • THERAPEUTIC TARGET
  • THERAPY – METHOTREXATE
  • THERAPY – NUCLEOSIDE ANALOGUES
  • PROGRESS CHECK
  • SECTION SUMMARY
  • INHIBITION OF INTRACELLULAR SIGNAL TRANSDUCTION
  • WHAT IS INTRACELLULAR SIGNAL TRANSDUCTION?
  • THERAPEUTIC TARGET
  • THERAPY – TYROSINE KINASE INHIBITORS
  • POP QUIZ
  • SECTION SUMMARY
  • ADDITIONAL TREATMENTS FOR ALL
  • SUPPORTIVE THERAPIES
  • STEM CELL TRANSPLANTATION
  • PALLIATIVE CARE
  • PROGRESS CHECK
  • SECTION SUMMARY
  • TEST YOUR ACQUIRED KNOWLEDGE
  • SUMMARY
  • FINAL ASSESSMENT
  • END OF PROGRAM
  • GLOSSARY
  •  

 

Delivery
Title
Understanding the Agents Used to Treat Acute Lymphoblastic Leukemia
Speciality Classification
Location
Provider Type
Education Provider
Duration
110 mins
CPD Points
1 cpd
Price
0.00
Location
Online
Contact Phone
Log in into view this field.
6 Views
Similar Courses and Events
  • Vertigo
  • Posted By Ausmed Education
  • Posted Date: 2019-11-18
  • Location:Melbourne VIC 3000
  • Vertigo is a symptom associated with the sensation of movement. It includes spinning, tilting and sw...
  • Pain Management
  • Posted By Ausmed Education
  • Posted Date: 2019-11-18
  • Location:Melbourne VIC 3000
  • Course Overview This Course will provide an overview of the pathophysiology, types, signs and sym...
HealthcareLink